(Solution) NR603 Week 5: APEA Predictor – Part 2
Total Points Possible: 70
Part 2- Due By Thursday 11:59 p.m. MT at the end of Week 5
Submit your First line treatment plan based on one dx from your differential list to the Case Study Submission area by 11:59pm MT Thursday night.
Week 5: APEA Predictor – Part 2
iagnosis and Treatment
Patient: Smith, Jane
Jane came in last week with complaints of fatigue.
There are many hemoglobin variants, make thalassemia a diagnosis of exclusion. Her serum iron and total iron-binding capacity was normal. Her B12 was within the normal range of (200-600pg/mL). TSH was within normal range (0.5-5.0mIU/L). Her CMP revealed normal kidney/liver function without sign of electrolyte imbalance. Her urine was clear from infection.
Her abnormal labs:
Hemoglobin 8.8 (13.5-17.5)
Hematocrit 29.8 (35.5-45.5)
RBC 2.98. (4.2-5.4)
MCV 65.4 (80-100)
MCH 19.3 (27.5-33.2)
Review of labs
The serum iron test measures the amount of iron in the blood, while the total iron binding capacity (TIBC) measures the availability of protein to be bound to iron. So, patients with iron deficiency anemia (IDA) will often have a serum iron that is decreased and a total iron-binding capacity that is increased. Jane’s levels were normal, so diagnosis was not leaning toward IDA……..Kindly click the purchase icon above to purchase the full solution at $10